Dual immuno-oncology agents as neoadjuvant therapy for patients with resectable non-small cell lung cancer.

ABSTRACT:

SUBMITTER: Adachi H 

PROVIDER: S-EPMC10938088 | biostudies-literature | 2024 Feb

REPOSITORIES: biostudies-literature